TY - JOUR
T1 - The burden of disease in Greece, health loss, risk factors, and health financing, 2000-16 : an analysis of the Global Burden of Disease Study 2016
AU - Tyrovolas, Stefanos
AU - Kassebaum, Nicholas J.
AU - Stergachis, Andy
AU - Abraha, Haftom Niguse
AU - Alla, Francois
AU - Androudi, Sofia
AU - Car, Mate
AU - Chrepa, Vanessa
AU - Furst, Thomas
AU - Fullman, Nancy
AU - Haro, Josep Maria
AU - Hay, Simon I.
AU - Jakovljevic, Mihajlo B.
AU - Jonas, Jost B.
AU - Khalil, Ibrahim A.
AU - Kopec, Jacek A.
AU - Manguerra, Helena
AU - Martopullo, Ira
AU - Mokdad, Ali
AU - Monasta, Lorenzo
AU - Nichols, Emma
AU - Olsen, Helen Elisabeth
AU - Rawaf, Salman
AU - Reiner, Robert
AU - Renzaho, Andre M. N.
AU - Ronfani, Luca
AU - Sanchez-Nino, Maria Dolores
AU - Sartorius, Benn
AU - Sawhney, Monika
AU - Alves, Silveira Dayane Gabriele
AU - Stathopoulou, Vasiliki
AU - Vollset, Emil Stein
AU - Stroumpoulis, Konstantinos
AU - Topor-Madry, Roman
AU - Topouzis, Fotis
AU - Tortajada-Girbes, Miguel
AU - Tsilimbaris, Miltiadis
AU - Tsilimparis, Nikolaos
AU - Valsamidis, Dimitrios
AU - van Boven, Job F. M.
AU - Violante, Francesco S.
AU - Werdecker, Andrea
AU - Westerman, Ronny
AU - Whiteford, Harvey A.
AU - Wolfe, Charles D. A.
AU - Younis, Mustafa Z.
AU - Kotsakis, Georgios A.
PY - 2018
Y1 - 2018
N2 - Background: Following the economic crisis in Greece in 2010, the country's ongoing austerity measures include a substantial contraction of health-care expenditure, with reports of subsequent negative health consequences. A comprehensive evaluation of mortality and morbidity is required to understand the current challenges of public health in Greece. Methods: We used the results of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 to describe the patterns of death and disability among those living in Greece from 2000 to 2010 (pre-austerity) and 2010 to 2016 (post-austerity), and compared trends in health outcomes and health expenditure to those in Cyprus and western Europe. We estimated all-cause mortality from vital registration data, and we calculated cause-specific deaths and years of life lost. Age-standardised mortality rates were compared using the annualised rate of change (ARC). Mortality risk factors were assessed using a comparative risk assessment framework for 84 risk factors and clusters to calculative summary exposure values and population attributable fraction statistics. We assessed the association between trends in total, government, out-of-pocket, and prepaid public health expenditure and all-cause mortality with a segmented correlation analysis.
AB - Background: Following the economic crisis in Greece in 2010, the country's ongoing austerity measures include a substantial contraction of health-care expenditure, with reports of subsequent negative health consequences. A comprehensive evaluation of mortality and morbidity is required to understand the current challenges of public health in Greece. Methods: We used the results of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 to describe the patterns of death and disability among those living in Greece from 2000 to 2010 (pre-austerity) and 2010 to 2016 (post-austerity), and compared trends in health outcomes and health expenditure to those in Cyprus and western Europe. We estimated all-cause mortality from vital registration data, and we calculated cause-specific deaths and years of life lost. Age-standardised mortality rates were compared using the annualised rate of change (ARC). Mortality risk factors were assessed using a comparative risk assessment framework for 84 risk factors and clusters to calculative summary exposure values and population attributable fraction statistics. We assessed the association between trends in total, government, out-of-pocket, and prepaid public health expenditure and all-cause mortality with a segmented correlation analysis.
KW - Greece
KW - medical care
KW - public health
UR - http://hdl.handle.net/1959.7/uws:49013
U2 - 10.1016/S2468-2667(18)30130-0
DO - 10.1016/S2468-2667(18)30130-0
M3 - Article
SN - 2468-2667
VL - 3
SP - E395-E406
JO - The Lancet Public Health
JF - The Lancet Public Health
IS - 8
ER -